Imaging Progression Under Low Respiratory Viral Load of SARS-CoV-2 Omicron Variant Infection: A Retrospective Study in China

References

• Umakanthan S, Sahu P, Ranade AV, et al. Origin, transmission, diagnosis and management of coronavirus disease 2019 (COVID-19). Postgrad Med J. 2020;96(1142):753–758. doi:10.1136/postgradmedj-2020-138234
   PubMed Web of Science ®Google Scholar
• Umakanthan S, Monice M, Mehboob S, Jones CL, Lawrence S. Post-acute (long) COVID-19 quality of life: validation of the German version of (PAC19QoL) instrument. Front Public Health. 2023;11:1163360. doi:10.3389/fpubh.2023.1163360
   PubMed Web of Science ®Google Scholar
• Thakur V, Ratho RK. OMICRON (B.1.1.529): a new SARS-CoV-2 variant of concern mounting worldwide fear. J Med Virol. 2022;94(5):1821–1824. doi:10.1002/jmv.27541
   PubMed Web of Science ®Google Scholar
• Nori W, Ghani Zghair MA. Omicron targets upper airways in pediatrics, elderly and unvaccinated population. World J Clin Cases. 2022;10(32):12062–12065. doi:10.12998/wjcc.v10.i32.12062
   PubMed Web of Science ®Google Scholar
• Gao Y, Cai C, Grifoni A, et al. Ancestral SARS-CoV-2-specific T cells cross-recognize the Omicron variant. Nat Med. 2022;28(3):472–476. doi:10.1038/s41591-022-01700-x
   PubMed Web of Science ®Google Scholar
• Kuhlmann C, Mayer CK, Claassen M, et al. Breakthrough infections with SARS-CoV-2 omicron despite mRNA vaccine booster dose. Lancet. 2022;399(10325):625–626. doi:10.1016/S0140-6736(22)00090-3
   PubMed Web of Science ®Google Scholar
• Hui KP, Ho JC, Cheung MC, et al. SARS-CoV-2 Omicron variant replication in human bronchus and lung ex vivo. Nature. 2022;603(7902):715–720. doi:10.1038/s41586-022-04479-6
   PubMed Web of Science ®Google Scholar
• Aranha C, Patel V, Bhor V, Gogoi D. Cycle threshold values in RT-PCR to determine dynamics of SARS-CoV-2 viral load: an approach to reduce the isolation period for COVID-19 patients. J Med Virol. 2021;93(12):6794–6797. doi:10.1002/jmv.27206
   PubMed Web of Science ®Google Scholar
• Pan F, Ye T, Sun P, et al. Time course of lung changes at chest CT during recovery from coronavirus disease 2019 (COVID-19). Radiology. 2020;295(3):715–721. doi:10.1148/radiol.2020200370
   PubMed Web of Science ®Google Scholar
• Pan Y, Guan H, Zhou S, et al. Initial CT findings and temporal changes in patients with the novel coronavirus pneumonia (2019-nCoV): a study of 63 patients in Wuhan, China. Eur Radiol. 2020;30(6):3306–3309. doi:10.1007/s00330-020-06731-x
   PubMed Web of Science ®Google Scholar
• Zhou Z, Guo D, Li C, et al. Coronavirus disease 2019: initial chest CT findings. Eur Radiol. 2020;30(8):4398–4406. doi:10.1007/s00330-020-06816-7
   PubMed Web of Science ®Google Scholar
• Yang R, Li X, Liu H, et al. Chest CT severity score: an imaging tool for assessing severe COVID-19. Radiol Cardiothorac Imaging. 2020;2(2):e200047. doi:10.1148/ryct.2020200047
   PubMedGoogle Scholar
• Xu Y, Chen Y, Tang X. Guidelines for the diagnosis and treatment of coronavirus disease 2019 (COVID-19) in China. Glob Health Med. 2020;2(2):66–72. doi:10.35772/ghm.2020.01015
   PubMedGoogle Scholar
• Yoon SH, Lee JH, Kim BN. Chest CT findings in hospitalized patients with SARS-CoV-2: Delta versus Omicron variants. Radiology. 2023;306(1):252–260. doi:10.1148/radiol.220676
   PubMed Web of Science ®Google Scholar
• Tsakok MT, Watson RA, Saujani SJ, et al. Reduction in chest CT severity and improved hospital outcomes in SARS-CoV-2 Omicron compared with Delta variant infection. Radiology. 2023;306(1):261–269. doi:10.1148/radiol.220533
   PubMed Web of Science ®Google Scholar
• Sievers C, Zacher B, Ullrich A, et al. SARS-CoV-2 Omicron variants BA.1 and BA.2 both show similarly reduced disease severity of COVID-19 compared to Delta, Germany, 2021 to 2022. Euro Surveill. 2022;27(22):2200396. doi:10.2807/1560-7917.ES.2022.27.22.2200396
   PubMedGoogle Scholar
• Wolter N, Jassat W, Walaza S, et al. Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study. Lancet. 2022;399(10323):437–446. doi:10.1016/S0140-6736(22)00017-4
   PubMed Web of Science ®Google Scholar
• Azkur AK, Akdis M, Azkur D, et al. Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19. Allergy. 2020;75(7):1564–1581. doi:10.1111/all.14364
   PubMed Web of Science ®Google Scholar
• Paces J, Strizova Z, Smrz D, Cerny J. COVID-19 and the immune system. Physiol Res. 2020;69(3):379–388. doi:10.33549/physiolres.934492
   PubMed Web of Science ®Google Scholar
• Guo L, Ren L, Yang S, et al. Profiling early humoral response to diagnose novel coronavirus disease (COVID-19). Clin Infect Dis. 2020;71(15):778–785. doi:10.1093/cid/ciaa310
   PubMed Web of Science ®Google Scholar
• Long QX, Liu BZ, Deng HJ, et al. Antibody responses to SARS-CoV-2 in patients with COVID-19. Nat Med. 2020;26(6):845–848. doi:10.1038/s41591-020-0897-1
   PubMed Web of Science ®Google Scholar
• Luo XH, Zhu Y, Mao J, Du RC. T cell immunobiology and cytokine storm of COVID-19. Scand J Immunol. 2021;93(3):e12989. doi:10.1111/sji.12989
   PubMed Web of Science ®Google Scholar
• Hu B, Huang S, Yin L. The cytokine storm and COVID-19. J Med Virol. 2021;93(1):250–256. doi:10.1002/jmv.26232
   PubMed Web of Science ®Google Scholar
• Yang L, Liu S, Liu J, et al. COVID-19: immunopathogenesis and immunotherapeutics. Signal Transduct Target Ther. 2020;5(1):128. doi:10.1038/s41392-020-00243-2
   PubMed Web of Science ®Google Scholar
• Strohl WR, Ku Z, An Z, Carroll SF, Keyt BA, Strohl LM. Passive immunotherapy against SARS-CoV-2: from plasma-based therapy to single potent antibodies in the race to stay ahead of the variants. BioDrugs. 2022;36(3):231–323. doi:10.1007/s40259-022-00529-7
   PubMed Web of Science ®Google Scholar
• Cheng ZJ, Li B, Zhan Z, et al. Clinical application of antibody immunity against SARS-CoV-2: comprehensive review on immunoassay and immunotherapy. Clin Rev Allergy Immunol. 2023;64(1):17–32. doi:10.1007/s12016-021-08912-y
   PubMed Web of Science ®Google Scholar
• Monzavi SM, Naderi M, Ahmadbeigi N, Kajbafzadeh AM, Muhammadnejad S. An outlook on antigen-specific adoptive immunotherapy for viral infections with a focus on COVID-19. Cell Immunol. 2021;367:104398. doi:10.1016/j.cellimm.2021.104398
   PubMed Web of Science ®Google Scholar
• Elshazli RM, Toraih EA, Elgaml A, et al. Diagnostic and prognostic value of hematological and immunological markers in COVID-19 infection: a meta-analysis of 6320 patients. PLoS One. 2020;15(8):e0238160. doi:10.1371/journal.pone.0238160
   PubMed Web of Science ®Google Scholar
• Ghahramani S, Tabrizi R, Lankarani KB, et al. Laboratory features of severe vs. non-severe COVID-19 patients in Asian populations: a systematic review and meta-analysis. Eur J Med Res. 2020;25(1):30. doi:10.1186/s40001-020-00432-3
   PubMed Web of Science ®Google Scholar